Elevated striatal dopamine function linked to prodromal signs of schizophrenia.

CONTEXT: A major limitation on the development of biomarkers and novel interventions for schizophrenia is that its pathogenesis is unknown. Although elevated striatal dopamine activity is thought to be fundamental to schizophrenia, it is unclear when this neurochemical abnormality develops in relati...

詳細記述

書誌詳細
主要な著者: Howes, O, Montgomery, A, Asselin, M, Murray, R, Valli, I, Tabraham, P, Bramon-Bosch, E, Valmaggia, L, Johns, L, Broome, M, McGuire, P, Grasby, P
フォーマット: Journal article
言語:English
出版事項: 2009